<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01274039</url>
  </required_header>
  <id_info>
    <org_study_id>AcetazolamideTrialCologne</org_study_id>
    <nct_id>NCT01274039</nct_id>
  </id_info>
  <brief_title>Comparing Eye Pressure Using Maximal Tolerated Local Therapy or Systemic Acetazolamide</brief_title>
  <official_title>Comparing Eye Pressure Using Maximal Tolerated Local Therapy or Systemic Acetazolamide. A Possible Pretreatment for Trabeculectomy Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cologne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Cologne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Local therapy for glaucoma is known to induce a conjunctival inflammation. Because of this,
      trabeculectomy is more likely to fail. The investigators exchange the local therapy by
      systemic therapy using acetazolamide and measure the eye pressure using local therapy and
      systemic therapy using acetazolamide. The investigators suspect an elevated eye pressure
      using acetazolamide compared to local therapy. In summary acetazolamide could be a better
      choice in reference to conjunctival inflammation, but a worse choice in reference to
      controlling eye pressure.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2009</start_date>
  <completion_date type="Actual">February 2012</completion_date>
  <primary_completion_date type="Actual">February 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Eye pressure</measure>
    <time_frame>Once at the beginning of the study and once 3 to 4 weeks later</time_frame>
    <description>The eye pressure is measured at the beginning of the study, when the patient is using the maximal tolerated local therapy and 3 to 4 weeks later, when using systemic acetazolamide treatment.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <condition>Control of Elevated Eye Pressure by Local and Systemic Therapy</condition>
  <arm_group>
    <arm_group_label>Patient with a trabeculectomy planed</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetazolamide for glaucoma patients to lower eye pressure</intervention_name>
    <description>Acetazolamide tablets 3 times daily for 3 to 4 weeks</description>
    <arm_group_label>Patient with a trabeculectomy planed</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients of the university hospital with a planed trabeculectomy in 3 to 4 weeks.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with uncontrolled intraocular eye pressure

          -  Patients with planed trabeculectomy in 3 to 4 weeks

        Exclusion Criteria:

          -  Patients not meeting the inclusion criteria

          -  Patients with known intolerance to acetazolamide
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Cologne</name>
      <address>
        <city>Cologne</city>
        <zip>50924</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 10, 2011</study_first_submitted>
  <study_first_submitted_qc>January 10, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 11, 2011</study_first_posted>
  <last_update_submitted>April 12, 2013</last_update_submitted>
  <last_update_submitted_qc>April 12, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 15, 2013</last_update_posted>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetazolamide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

